Efficacy of Ear Acupuncture in Preventing Chemotherapy Induced Nausea and Vomiting in Cancer Patients

Sponsor
Indonesia University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05851625
Collaborator
Mashhad University of Medical Sciences (Other)
64
1
2
6
10.6

Study Details

Study Description

Brief Summary

Chemotherapy is a cancer therapy performed on advanced cancer with quite good success, but this therapy has quite a lot of side effects. Chemotherapy induced nausea and vomiting or commonly known as CINV, is a condition of nausea and vomiting experienced by cancer patients undergoing chemotherapy, with a prevalence of around 80% of all patients undergoing chemotherapy, and 40% has the potential to become severe. This study aims to determine the efficacy of a new acupuncture modality, namely the press needle, in preventing CINV symptoms in pediatric patients with cancer undergoing chemotherapy.

The study was conducted using a randomized controlled clinical trial (RCT) design in 64 pediatric cancer patients undergoing chemotherapy who were randomized into 2 groups, namely: (1) standard medical therapy as the control group; and (2) a combination of standard therapy with press needle acupuncture as the treatment group. The ear acupuncture points used are Shenmen and Stomach, and one body acupuncture point is PC6. Outcome measurements were carried out in the form of the RINVR questionnaire to assess the intensity of nausea and vomiting measured at 4 times: (1) 3 days before chemotherapy; (2) days of chemotherapy; (3) 12 hours after chemotherapy; (4) 3 days after chemotherapy.

Condition or Disease Intervention/Treatment Phase
  • Device: Press needle acupuncture
  • Device: Plesterin
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
64 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Primary Purpose:
Prevention
Official Title:
Efficacy of Ear Acupuncture in Preventing Chemotherapy Induced Nausea and Vomiting in Cancer Patients
Anticipated Study Start Date :
Jul 1, 2023
Anticipated Primary Completion Date :
Nov 1, 2023
Anticipated Study Completion Date :
Dec 31, 2023

Arms and Interventions

Arm Intervention/Treatment
Placebo Comparator: Placebo

The control group was given a placebo press needle acupuncture (using plaster) with standard medical therapy for CINV prevention.

Device: Plesterin
The plaster used is a round plaster that resembles the shape of an acupuncture press needle.

Experimental: Acupuncture

The intervention group was given press needle acupuncture with standard medical therapy for CINV prevention.

Device: Press needle acupuncture
Press needle acupuncture is a modality of acupuncture using tiny and very thin needles.

Outcome Measures

Primary Outcome Measures

  1. Rhodes Index of Nausea, Vomiting, and Retching (RINVR) questionnaire [9 days]

    Method instrument for assessing nausea and vomiting consisting of eight statements

Eligibility Criteria

Criteria

Ages Eligible for Study:
6 Years to 18 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Pediatric patients with cancer who are undergoing chemotherapy.

  • Age 6 - 18 years.

  • Patients with platelet counts > 20,000/μL and neutrophil values > 1,000/μL.

  • Willing to follow the research.

Exclusion Criteria:
  • Patients with local infection in the puncture area.

  • Patients with anatomic abnormalities in the auricle.

  • Did not complete the acupuncture therapy until it was finished (three days after chemotherapy).

Contacts and Locations

Locations

Site City State Country Postal Code
1 RSUPN Dr. Cipto Mangunkusumo Jakarta DKI Jakarta Indonesia 10430

Sponsors and Collaborators

  • Indonesia University
  • Mashhad University of Medical Sciences

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Wahyuningsih Djaali, Lecturer of Indonesia University, Indonesia University
ClinicalTrials.gov Identifier:
NCT05851625
Other Study ID Numbers:
  • 19944
First Posted:
May 10, 2023
Last Update Posted:
May 10, 2023
Last Verified:
May 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Wahyuningsih Djaali, Lecturer of Indonesia University, Indonesia University
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 10, 2023